Novo Nordisk A S
NONOF- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000353278
No open-market purchases or sales by Novo Nordisk A S insiders were filed in the last 90 days; 3 institutions reported holding it in 13F filings for Q2 2026, worth $5.36M in total; no superinvestor holds it.
Other share classesNVO
Q4 2025 vs. Q3 2025
How the institutions holding Novo Nordisk A S changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 3 | 2 | −1 |
| Shares | 20.7K | 5.28K | −15.5K (−74.6%) |
| Value | $1.12M | $269.4K | −$855.3K (−76.0%) |
New holders (1)
Institutions that held Novo Nordisk A S at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Atlas Capital Advisors LLC | 5,218 | $266.4K | 0.03% |
Sold out (2)
Institutions that held Novo Nordisk A S at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Saranac Partners Ltd | 13,431 | $728.6K |
| LBMC Investment Advisors, LLC | 7,250 | $392.8K |